In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Neotropix, Inc.

Latest From Neotropix, Inc.

Novartis's dispersible ACT treatment set to improve malaria treatment in children

A new formulation of the malaria treatment Coartem designed specifically for children has been developed and launched by Novartisand the Medicines for Malaria Venture(MMV).

Neotropix Inc.

Neotropix Inc. believes it is on the right track to develop a virus that just infects cancer cells, at least for cancers with specific neuroendocrine properties -- a feat that would amount to the mythic "silver bullet" cancer cure.

BioPharmaceutical

Start-Up Previews (5/05)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, New Approaches to Heart Valve Repair and Replacement, features profiles of 3F Therapeutics, Arbor Surgical Technologies and Heart Leaflet Technologies. Plus these Start-Ups Across Health Care: Neotropix, NeuroHealing Pharmaceuticals, Othera Pharmaceuticals and Vitra Bioscience.

See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
UsernamePublicRestriction

Register